| UniProt ID | RBNS5_HUMAN | |
|---|---|---|
| UniProt AC | Q9H1K0 | |
| Protein Name | Rabenosyn-5 {ECO:0000303|PubMed:11062261} | |
| Gene Name | RBSN {ECO:0000312|HGNC:HGNC:20759} | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 784 | |
| Subcellular Localization |
Cell membrane Lipid-anchor Cytoplasmic side. Early endosome membrane Lipid-anchor. Enriched in endosomes that are in close proximity to clathrin-enriched regions at the cell surface. |
|
| Protein Description | Rab4/Rab5 effector protein acting in early endocytic membrane fusion and membrane trafficking of recycling endosomes. Required for endosome fusion either homotypically or with clathrin coated vesicles. Plays a role in the lysosomal trafficking of CTSD/cathepsin D from the Golgi to lysosomes. Also promotes the recycling of transferrin directly from early endosomes to the plasma membrane. Binds phospholipid vesicles containing phosphatidylinositol 3-phosphate (PtdInsP3). [PubMed: 11062261] | |
| Protein Sequence | MASLDDPGEVREGFLCPLCLKDLQSFYQLHSHYEEEHSGEDRDVKGQIKSLVQKAKKAKDRLLKREGDDRAESGTQGYESFSYGGVDPYMWEPQELGAVRSHLSDFKKHRAARIDHYVVEVNKLIIRLEKLTAFDRTNTESAKIRAIEKSVVPWVNDQDVPFCPDCGNKFSIRNRRHHCRLCGSIMCKKCMELISLPLANKLTSASKESLSTHTSPSQSPNSVHGSRRGSISSMSSVSSVLDEKDDDRIRCCTHCKDTLLKREQQIDEKEHTPDIVKLYEKLRLCMEKVDQKAPEYIRMAASLNAGETTYSLEHASDLRVEVQKVYELIDALSKKILTLGLNQDPPPHPSNLRLQRMIRYSATLFVQEKLLGLMSLPTKEQFEELKKKRKEEMERKRAVERQAALESQRRLEERQSGLASRAANGEVASLRRGPAPLRKAEGWLPLSGGQGQSEDSDPLLQQIHNITSFIRQAKAAGRMDEVRTLQENLRQLQDEYDQQQTEKAIELSRRQAEEEDLQREQLQMLRERELEREREQFRVASLHTRTRSLDFREIGPFQLEPSREPRTHLAYALDLGSSPVPSSTAPKTPSLSSTQPTRVWSGPPAVGQERLPQSSMPQQHEGPSLNPFDEEDLSSPMEEATTGPPAAGVSLDPSARILKEYNPFEEEDEEEEAVAGNPFIQPDSPAPNPFSEEDEHPQQRLSSPLVPGNPFEEPTCINPFEMDSDSGPEAEEPIEEELLLQQIDNIKAYIFDAKQCGRLDEVEVLTENLRELKHTLAKQKGGTD | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MASLDDPGE ------CCCCCCCCC | 20.85 | 22814378 | |
| 3 | Phosphorylation | -----MASLDDPGEV -----CCCCCCCCCC | 30.91 | 23186163 | |
| 117 | Phosphorylation | RAARIDHYVVEVNKL HHHHCCEEEEHHHHH | 11.48 | 27642862 | |
| 169 | Acetylation | FCPDCGNKFSIRNRR CCCCCCCCEEECCCH | 26.27 | 26051181 | |
| 204 | Phosphorylation | PLANKLTSASKESLS HHHHHCCCCCHHHHC | 40.77 | 30624053 | |
| 209 | Phosphorylation | LTSASKESLSTHTSP CCCCCHHHHCCCCCC | 31.21 | 29255136 | |
| 211 | Phosphorylation | SASKESLSTHTSPSQ CCCHHHHCCCCCCCC | 27.67 | 29255136 | |
| 212 | Phosphorylation | ASKESLSTHTSPSQS CCHHHHCCCCCCCCC | 34.17 | 29255136 | |
| 214 | Phosphorylation | KESLSTHTSPSQSPN HHHHCCCCCCCCCCC | 42.28 | 29255136 | |
| 215 | Phosphorylation | ESLSTHTSPSQSPNS HHHCCCCCCCCCCCC | 18.23 | 29255136 | |
| 217 | Phosphorylation | LSTHTSPSQSPNSVH HCCCCCCCCCCCCCC | 42.95 | 29255136 | |
| 219 | Phosphorylation | THTSPSQSPNSVHGS CCCCCCCCCCCCCCC | 30.32 | 29255136 | |
| 222 | Phosphorylation | SPSQSPNSVHGSRRG CCCCCCCCCCCCCCC | 20.90 | 29255136 | |
| 226 | Phosphorylation | SPNSVHGSRRGSISS CCCCCCCCCCCCHHC | 12.15 | 29255136 | |
| 230 | Phosphorylation | VHGSRRGSISSMSSV CCCCCCCCHHCCHHH | 19.93 | 30278072 | |
| 232 | Phosphorylation | GSRRGSISSMSSVSS CCCCCCHHCCHHHHH | 22.99 | 25159151 | |
| 233 | Phosphorylation | SRRGSISSMSSVSSV CCCCCHHCCHHHHHH | 22.48 | 30278072 | |
| 235 | Phosphorylation | RGSISSMSSVSSVLD CCCHHCCHHHHHHCC | 29.54 | 25159151 | |
| 236 | Phosphorylation | GSISSMSSVSSVLDE CCHHCCHHHHHHCCC | 19.85 | 25159151 | |
| 238 | Phosphorylation | ISSMSSVSSVLDEKD HHCCHHHHHHCCCCC | 19.37 | 28450419 | |
| 239 | Phosphorylation | SSMSSVSSVLDEKDD HCCHHHHHHCCCCCC | 25.25 | 28450419 | |
| 277 | Ubiquitination | EHTPDIVKLYEKLRL CCCHHHHHHHHHHHH | 45.76 | - | |
| 288 | Acetylation | KLRLCMEKVDQKAPE HHHHHHHHHHHHCHH | 24.99 | 25953088 | |
| 375 | Phosphorylation | EKLLGLMSLPTKEQF HHHHCHHCCCCHHHH | 35.92 | - | |
| 378 | Phosphorylation | LGLMSLPTKEQFEEL HCHHCCCCHHHHHHH | 53.13 | - | |
| 416 | Phosphorylation | RRLEERQSGLASRAA HHHHHHHHHHHHHHH | 41.83 | 28555341 | |
| 429 | Phosphorylation | AANGEVASLRRGPAP HHCCCHHHCCCCCCC | 27.82 | 23917254 | |
| 439 | Ubiquitination | RGPAPLRKAEGWLPL CCCCCCCCCCCCEEC | 59.48 | - | |
| 496 | Phosphorylation | LRQLQDEYDQQQTEK HHHHHHHHHHHHHHH | 27.60 | 21659604 | |
| 501 | Phosphorylation | DEYDQQQTEKAIELS HHHHHHHHHHHHHHH | 34.81 | 21659604 | |
| 541 | Phosphorylation | REQFRVASLHTRTRS HHHHHHHHHHHHCCC | 20.16 | 26657352 | |
| 544 | Phosphorylation | FRVASLHTRTRSLDF HHHHHHHHHCCCCCH | 38.74 | 27251275 | |
| 546 | Phosphorylation | VASLHTRTRSLDFRE HHHHHHHCCCCCHHH | 26.26 | 30266825 | |
| 548 | Phosphorylation | SLHTRTRSLDFREIG HHHHHCCCCCHHHCC | 31.51 | 23401153 | |
| 567 | Phosphorylation | EPSREPRTHLAYALD CCCCCCCCEEEEEHH | 31.77 | 27080861 | |
| 571 | Phosphorylation | EPRTHLAYALDLGSS CCCCEEEEEHHCCCC | 17.66 | 27080861 | |
| 577 | Phosphorylation | AYALDLGSSPVPSST EEEHHCCCCCCCCCC | 38.47 | 22199227 | |
| 578 | Phosphorylation | YALDLGSSPVPSSTA EEHHCCCCCCCCCCC | 28.28 | 22199227 | |
| 583 | O-linked_Glycosylation | GSSPVPSSTAPKTPS CCCCCCCCCCCCCCC | 23.63 | 30059200 | |
| 588 | Phosphorylation | PSSTAPKTPSLSSTQ CCCCCCCCCCCCCCC | 19.63 | 22199227 | |
| 590 | Phosphorylation | STAPKTPSLSSTQPT CCCCCCCCCCCCCCC | 46.22 | 22199227 | |
| 601 | Phosphorylation | TQPTRVWSGPPAVGQ CCCCEEECCCCCCCC | 38.27 | 25159151 | |
| 634 | Phosphorylation | PFDEEDLSSPMEEAT CCCHHHCCCCCHHHC | 44.72 | 28348404 | |
| 635 | Phosphorylation | FDEEDLSSPMEEATT CCHHHCCCCCHHHCC | 35.25 | 28348404 | |
| 641 | Phosphorylation | SSPMEEATTGPPAAG CCCCHHHCCCCCCCC | 35.25 | 28348404 | |
| 642 | Phosphorylation | SPMEEATTGPPAAGV CCCHHHCCCCCCCCC | 55.53 | 28348404 | |
| 684 | Phosphorylation | NPFIQPDSPAPNPFS CCCCCCCCCCCCCCC | 29.64 | 26657352 | |
| 691 | Phosphorylation | SPAPNPFSEEDEHPQ CCCCCCCCCCCCCCC | 41.14 | 22210691 | |
| 715 | Phosphorylation | GNPFEEPTCINPFEM CCCCCCCCCCCCCCC | 29.33 | 27251275 | |
| 724 | Phosphorylation | INPFEMDSDSGPEAE CCCCCCCCCCCCCCC | 32.16 | 27251275 | |
| 726 | Phosphorylation | PFEMDSDSGPEAEEP CCCCCCCCCCCCCCC | 61.26 | 27251275 | |
| 773 | Ubiquitination | TENLRELKHTLAKQK HHHHHHHHHHHHHHC | 29.77 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 215 | S | Phosphorylation | Kinase | MAPK14 | Q16539 | GPS |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RBNS5_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RBNS5_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| RAB5A_HUMAN | RAB5A | physical | 11062261 | |
| VPS45_HUMAN | VPS45 | physical | 19931244 | |
| FAK1_HUMAN | PTK2 | physical | 19931244 | |
| HSP7C_HUMAN | HSPA8 | physical | 19931244 | |
| VPS45_RAT | Vps45 | physical | 19931244 | |
| RAB5A_HUMAN | RAB5A | physical | 16034420 | |
| RAB4A_HUMAN | RAB4A | physical | 16034420 | |
| RB22A_HUMAN | RAB22A | physical | 16034420 | |
| RAB14_HUMAN | RAB14 | physical | 16034420 | |
| RAB24_HUMAN | RAB24 | physical | 16034420 | |
| VPS45_HUMAN | VPS45 | physical | 28514442 | |
| EHD3_HUMAN | EHD3 | physical | 28514442 | |
| EHD4_HUMAN | EHD4 | physical | 28514442 | |
| AVIL_HUMAN | AVIL | physical | 28514442 | |
| PCDA4_HUMAN | PCDHA4 | physical | 28514442 | |
| IFFO1_HUMAN | IFFO1 | physical | 28514442 | |
| EHD1_HUMAN | EHD1 | physical | 28514442 | |
| LMX1B_HUMAN | LMX1B | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-214; SER-215 ANDSER-217, AND MASS SPECTROMETRY. | |
| "A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-601, AND MASSSPECTROMETRY. | |